Outset Medical, Inc. (OM)
Outset Medical, Inc. brought in $117.8M of revenue over the twelve months to June 30, 2026, down 1.3% from a year earlier. It posted a net loss of $74.3M. In fiscal 2025 capital spending exceeded operating cash flow by $47.1M. At June 30, 2026 it held $35M in cash against $97.6M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 6, 2026.
Key facts about Outset Medical, Inc.
- Net worth
- Outset Medical, Inc. has a market value (market cap) of $78M at the latest share price, and shareholders' equity of $96.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $119.5M (+5.1% year on year), with a net loss of $81.7M. Over the 12 months to June 30, 2026: revenue $117.8M, net loss $74.3M.
- Cash flow
- In fiscal 2025 operations used $46.3M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 6, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Outset Medical, Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
What Outset Medical, Inc. does
Outset Medical, Inc. is registered with the SEC under industry code SIC 3845 (Electromedical & Electrotherapeutic Apparatus). Its shares trade on NASDAQ under the ticker OM.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $119.5M | -$81.7M | -$5.37 | -$47.1M |
| 2024 | $113.7M | -$128M | -$36.96 | -$117.2M |
| 2023 | $130.4M | -$172.8M | -$52.28 | -$134.8M |
| 2022 | $115.4M | -$163M | -$50.78 | -$154.1M |
| 2021 | $102.6M | -$131.9M | -$43.42 | -$133.4M |
| 2020 | $49.9M | -$121.5M | -$72.86 | -$108.1M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where OM ranks in Health care
Latest SEC filings
What Outset Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 6, 2026Passive stake changed SCHEDULE 13G/A
- August 28, 2026
- August 12, 2026Passive stake changed SCHEDULE 13G/A
- August 12, 2026Passive stake (5% or more) SCHEDULE 13G
- August 6, 2026Quarterly report 10-Q · period to June 30, 2026Revenue rose 0.7% to $31.6M versus the same quarter last year; diluted EPS -$0.97 versus -$1.04.
- August 6, 2026
- July 29, 2026Passive stake changed SCHEDULE 13G/A
- June 17, 2026
- June 5, 2026
- May 29, 2026
Insider trades
What the people running Outset Medical, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
Insiders bought $870.3K and sold $46.6K worth of shares in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| October 2, 2026 | Leonard Braden Michael10% owner | Boughtindirect | 16,575 | $64.2K |
| October 1, 2026 | Leonard Braden Michael10% owner | Boughtindirect | 228,334 | $806K |
| August 17, 2026 | Gaeta ReneeChief Financial Officer | Sold | 4,543 | $19.9K |
| August 17, 2026 | Brottem John L.General Counsel | Sold | 2,632 | $11.6K |
| August 17, 2026 | Trigg LeslieChair and CEO, Director | Sold | 3,437 | $15.1K |
| June 26, 2026 | Trigg LeslieChair and CEO, Director | Received as pay | 99,160 | - |
| June 26, 2026 | Gaeta ReneeChief Financial Officer | Received as pay | 71,630 | - |
| June 26, 2026 | Brottem John L.General Counsel | Received as pay | 59,830 | - |
Who owns OM
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Fmr LLC13G, passive with 1 related filers | 14.5% | April 7, 2025 |
| BML Investment Partners, L.P.13G, passive | 13.6% | May 18, 2026 |
| Perceptive Advisors LLC13G, passive with 3 related filers | 6.7% | May 15, 2025 |
| AQR Capital Management, LLC13G, passive with 1 related filers | 5.39% | August 12, 2026 |
Largest institutional holders
Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 93 managers reported a position.
| Holder | Shares | Change on quarter |
|---|---|---|
| Fmr LLC | 2,742,887 | +1,214 |
| BML Capital Management, LLC | 2,519,701 | +617,500 |
| Aqr Capital Management LLC | 998,961 | +190,676 |
| Perceptive Advisors LLC | 833,333 | 0 |
| Vanguard Capital Management LLC | 780,134 | +16,312 |
| Assenagon Asset Management S.A. | 678,876 | +174,783 |
| Bank of America Corp | 665,847 | -283,550 |
| PFM Health Sciences, LP | 582,122 | -12,508 |
| Ensign Peak Advisors, Inc | 434,341 | -92,244 |
| BlackRock, Inc. | 418,211 | -845,008 |
| Peapod Lane Capital LLC | 331,951 | new |
| Marshall Wace, Llp | 211,993 | new |
| Geode Capital Management, LLC | 204,652 | -216,721 |
| Stratos Wealth Partners, LTD. | 200,546 | 0 |
| UBS Group AG | 190,289 | -62,210 |
| Morgan Stanley | 181,983 | +12,540 |
| Millennium Management LLC | 181,794 | new |
| Goldman Sachs Group Inc | 173,460 | +80,100 |
| Jane Street Group, LLC | 139,197 | +74,387 |
| XTX Topco Ltd | 124,690 | -17,760 |
Insiders
12 insiders reported holding 3,606,293 shares in total, about $15M at the last price.
| Holder | Shares |
|---|---|
| Leonard Braden Michael10% owner | 2,764,6102,764,610 held indirectly |
| Trigg LeslieChair and CEO, Director | 194,597 |
| Gaeta ReneeChief Financial Officer | 180,840 |
| Hackett Patrick TDirector | 105,839 |
| Elliott Derick A.EVP, Commercial | 96,000 |
| Brottem John L.General Counsel | 87,475 |
| Nash MarcEVP Operations R&D & Service | 38,393 |
| Oboyle Kevin CDirector | 34,785 |
| Prange KarenDirector | 29,334 |
| Lang Brent D.Director | 28,518 |
Questions about OM
What does Outset Medical, Inc. do?
Outset Medical, Inc. is a company in the Health care sector, listed on NASDAQ as OM. Its shares trade on NASDAQ under the ticker OM.
What is Outset Medical, Inc.'s net worth?
Outset Medical, Inc. has a market value (market cap) of $78M at the latest share price, and shareholders' equity of $96.3M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Outset Medical, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $74.3M on revenue of $117.8M.
How much revenue does Outset Medical, Inc. make?
Over the twelve months to June 30, 2026 Outset Medical, Inc. reported revenue of $117.8M. That is 1.3% less than a year earlier.
When did Outset Medical, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 6, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the passive stake changed from October 6, 2026.
When is Outset Medical, Inc.'s next earnings report?
Outset Medical, Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
Similar companies
Compare OM with
Follow OM
Get an email when Outset Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Outset Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.